Askimed

The next-generation eCRF system designed for medical trials in the cloud. Developed by researchers from the Medical University of Innsbruck.

[Lukas Forer @lukfor]

Making @nextflowio pipelines testable 🚀 @seppinho and I are happy to announce a first preview version of nf-test, a simple and elegant test framework to describe the expected behaviour of pipelines.

https://t.co/EcSDYeopH8

[Askimed @askimed_com]

What a year for Askimed 🚀. We really enjoy working with all of you! @imed_tweets @uniinnsbruck @UMIT_University @SwissTPH @LenaTschiderer @PeterWilleit @DorotheeLaer @JanineKimpel @chiara_herzog @UweSiebert9 @LSeekircher @bindernutrition AND and all others not on twitter.

[Askimed @askimed_com]

The #DiabLandeck study comes to an end. We supported the study team with an on-premise installation for eCRF data collection + initial data transfer from good old Access https://t.co/ZHExFlFBfu
@UMIT_University #ecrf

[Askimed @askimed_com]

Yet another important #COVID19 study that used the power of Askimed: on-site data collection + survey module for weekly follow-ups ✅
https://t.co/QUg0oLHuRB @imed_tweets #ecrf

[Askimed @askimed_com]

First results of the HEVACC Study using Askimed's data collection + survey feature are out. Preliminary results show that a heterologous vaccination leads to a stronger immune response #ecrf #survey #clinicaltrial

[Askimed @askimed_com]

Really cool to see this work out. Data collection was performed on-site (Ischgl) using our eCRF system. Collection run smoothly + great feedback from the interviewers on Askimed's usability. 😌
Congrats to all! #busridetoischgl #qrcodescanning #nopaper #COVID19 #ecrf

[Hannes Winner @hwin365]

Our study on the persistency of #immunity to #SARSCoV2 in the ski resort of #Ischgl is now out in @EBioMedicine, published by @TheLancet -- great collaboration between @imed_tweets
and @PLUS_1622 (@JorgPaetzold & @hwin365)!

https://t.co/BatvSP9Vuw

[Askimed @askimed_com]

This spring we made our platform available to the REDUCE study to transform 12,500 questionnaires to digital data. Huge effort from @PeterWilleit and his team (@LenaTschiderer, Lisa Seekircher). #doubledataentry #labelprinting #COVID19 @imed_tweets

https://t.co/M9u6VnbIsP

[Askimed @askimed_com]

.@seppinho and @lukfor from the Askimed team had the chance to co-author this paper with strong support from @KronenbergLab. Link to the paper: https://t.co/NObvFeo7RE
#COVID19 #lockdown #hardwork #ecrf #clinicaltrials

[Askimed @askimed_com]

Last year we had the chance to support this #COVID19 trial with our eCRF platform. Thrilled to see this now published in @LancetRespirMed lead by Axel Bauer @imed_tweets and Steffen Massberg @LMU_Uniklinikum. Fantastic team work. 20 centers, 300 users and we were live in 3 weeks

[Askimed @askimed_com]

Great to see the progress in the TirolGESUND study 🚀 Congrats to Chiara, Martin and the complete team. We are really happy to support this study with our platform. If you have a study a mind 🧠, contact us or write @SinaTschiderer directly. #surveys #edc

[Dr Chiara Herzog @chiara_herzog]

First #TirolGESUND participant recruitment week has easily been my most stressful week ever, but it's so rewarding to work with real people who are interested in improving their health and being able to helping them. I'm really proud what the team and I have achieved so far.

[Dr Chiara Herzog @chiara_herzog]

I should probably add, setting up this study has taken almost year and is a massive team effort with collaborators from @uniinnsbruck, @imed_tweets @UMIT_University and @tirol_kliniken, @askimed_com and it couldn’t have happened without the amazing team work so far.

[Dr Chiara Herzog @chiara_herzog]

First #TirolGESUND participant recruitment week has easily been my most stressful week ever, but it's so rewarding to work with real people who are interested in improving their health and being able to helping them. I'm really proud what the team and I have achieved so far.

[Sebastian Schönherr @seppinho]

We (@askimed_com) are back in Ischgl (Tirol, Austria) to support the #COVID19 study from the Institute of Virology @imed_tweets. great to see that so many people from Ischgl are here to support the science behind #COVID19. #ECRF #ischgl

[Askimed @askimed_com]

Last week, we went to Ischgl to do the data collection for a COVID-19 GWAS. #covid19 #ecrf #edc #cloud #askimed
https://t.co/ckP4JlTdRP